
|Articles|March 10, 2021
Application Note: AAV CQA analysis by SEC-MALS
Author(s)Wyatt Technology
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.